Boill Healthcare Holdings Limited

SEHK:1246 Stock Report

Market Cap: HK$407.4m

Boill Healthcare Holdings Future Growth

Future criteria checks 0/6

We currently don't have sufficient analyst coverage to forecast growth and revenue for Boill Healthcare Holdings.

Key information

n/a

Earnings growth rate

n/a

EPS growth rate

Real Estate earnings growth13.8%
Revenue growth raten/a
Future return on equityn/a
Analyst coverage

None

Last updatedn/a

Recent future growth updates

Recent updates

The Price Is Right For Boill Healthcare Holdings Limited (HKG:1246) Even After Diving 26%

Apr 18
The Price Is Right For Boill Healthcare Holdings Limited (HKG:1246) Even After Diving 26%

Positive Sentiment Still Eludes Boill Healthcare Holdings Limited (HKG:1246) Following 33% Share Price Slump

Feb 05
Positive Sentiment Still Eludes Boill Healthcare Holdings Limited (HKG:1246) Following 33% Share Price Slump

Boill Healthcare Holdings (HKG:1246) Has Debt But No Earnings; Should You Worry?

Jul 31
Boill Healthcare Holdings (HKG:1246) Has Debt But No Earnings; Should You Worry?

Lacklustre Performance Is Driving Boill Healthcare Holdings Limited's (HKG:1246) Low P/S

Apr 18
Lacklustre Performance Is Driving Boill Healthcare Holdings Limited's (HKG:1246) Low P/S

There's Been No Shortage Of Growth Recently For Boill Healthcare Holdings' (HKG:1246) Returns On Capital

Jul 22
There's Been No Shortage Of Growth Recently For Boill Healthcare Holdings' (HKG:1246) Returns On Capital

Is Boill Healthcare Holdings (HKG:1246) A Risky Investment?

Jul 13
Is Boill Healthcare Holdings (HKG:1246) A Risky Investment?

Is Boill Healthcare Holdings (HKG:1246) A Risky Investment?

Mar 21
Is Boill Healthcare Holdings (HKG:1246) A Risky Investment?

Have Insiders Been Buying Boill Healthcare Holdings Limited (HKG:1246) Shares This Year?

Jan 27
Have Insiders Been Buying Boill Healthcare Holdings Limited (HKG:1246) Shares This Year?

Is Boill Healthcare Holdings (HKG:1246) A Risky Investment?

Dec 05
Is Boill Healthcare Holdings (HKG:1246) A Risky Investment?

In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as Boill Healthcare Holdings has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.

This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.

Earnings and Revenue Growth Forecasts

SEHK:1246 - Analysts future estimates and past financials data (HKD Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
9/30/2023355-203-34-34N/A
6/30/2023352-2131717N/A
3/31/2023348-2246868N/A
9/30/2022430-30-11-12N/A
6/30/2022717-21-62-63N/A
3/31/20221,005-12-114-114N/A
12/31/20211,028-299-170-168N/A
9/30/20211,039-81-222-222N/A
6/30/2021628-112-188-188N/A
3/31/2021217-142-153-153N/A
12/31/2020139-172-84-85N/A
9/30/202061-201-15-16N/A
6/30/202084-1952628N/A
3/31/2020106-1896873N/A
12/31/2019227-185215230N/A
9/30/2019347-181362388N/A
6/30/2019384-190382407N/A
3/31/2019420-200402426N/A
12/31/2018572-232N/AN/AN/A
9/30/2018724-237382388N/A
6/30/2018731-225339342N/A
3/31/2018738-214295297N/A
12/31/2017616-298N/AN/AN/A
9/30/2017459-4121011N/A
6/30/2017473-491N/A-73N/A
3/31/2017487-570N/A-157N/A
12/31/2016492-450N/A-308N/A
9/30/2016485-327N/A-371N/A
6/30/2016509-260N/A-313N/A
3/31/2016532-193N/A-254N/A
12/31/2015512-113N/A-121N/A
9/30/2015492-33N/A12N/A
6/30/201552529N/A35N/A
3/31/201555891N/A58N/A
12/31/201456284N/A73N/A
9/30/201456678N/A88N/A
6/30/201452776N/A70N/A
3/31/201448773N/A51N/A
12/31/201344169N/A57N/A
9/30/201339564N/A62N/A
6/30/201337563N/A69N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: Insufficient data to determine if 1246's forecast earnings growth is above the savings rate (2.2%).

Earnings vs Market: Insufficient data to determine if 1246's earnings are forecast to grow faster than the Hong Kong market

High Growth Earnings: Insufficient data to determine if 1246's earnings are expected to grow significantly over the next 3 years.

Revenue vs Market: Insufficient data to determine if 1246's revenue is forecast to grow faster than the Hong Kong market.

High Growth Revenue: Insufficient data to determine if 1246's revenue is forecast to grow faster than 20% per year.


Earnings per Share Growth Forecasts


Future Return on Equity

Future ROE: Insufficient data to determine if 1246's Return on Equity is forecast to be high in 3 years time


Discover growth companies

Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.